Clinical trial
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study
NCT00105274 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00105274 |
|---|---|
| Title | Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study |
| Official title | Intermediate Phenotype and Genetic Mechanisms for Psychosis and Cognitive Disturbance in 22q11.2-Hemideletion Syndrome |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | DiGeorge Syndrome, Velocardiofacial Syndrome, 22q11.2 Syndrome |
| Start date | Mar 7, 2005 |
| Completion | Feb 2, 2010 |
| First posted | Mar 11, 2005 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: